OR WAIT null SECS
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
August 02, 2023
The ROSS Model CDA-200 is fitted with multiple agitators for semi-continuous operation.
Sphere Fluidics’ Cyto-Mine is an automated cell line platform that is designed to enable screening of up to 40 million cells over the course of several hours.
Eurofins Genomics Blue Heron IVT mRNA synthesis service is designed to provide researchers a customizable solution.
Thermo Fisher Scientific’s Gibco OncePro Tumoroid Culture Medium Kit was specifically developed for the expansion of patient-derived tumoroids from multiple cancer indications.
Environmental monitoring data can help keep sterile environments sterile.
July 31, 2023
The new facility is set to utilize and extend SCG's capabilities in advanced cell therapy manufacturing and off-the-shelf human-induced Pluripotent Stem Cell (iPSC) technology.
July 28, 2023
The expansion project is aimed to be completed in December 2024 and the new facility will be fully operational by 2025.
July 27, 2023
Teva Pharmaceuticals and Alvotech will expand their partnership for the development and commercialization of biosimilar candidates.
MilliporeSigma has invested $25 million to expand its cell culture media production facility in Lenexa, Kan.
July 24, 2023
WuXi STA’s new high-potency injectable line has an annual capacity of 12 million units.